CAMP

CAMP4 THERAPEUTICS CORP

CAMP·13463J101·US·Common Stock·Healthcare - Biotechnology-Activist

CAMP (CAMP4 THERAPEUTICS CORP) is held by 29 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($27.9M), FMR LLC ($21.8M), BALYASNY ASSET MANAGEMENT L.P. ($11.6M). Net institutional sentiment: Mixed.

29
Holders
Avg rating(5 Elite)
$86.3M
Total Value
64% (35)
Fund Consensus
21 buying - 12 selling
CAMPSmart Money Verdict
View all
Held by 29 funds
5 elite
Who's Trading
ActivistBalyasny Asset Management L.P.Balyasny Asset Management L.P.5.1%May 15, 2026
ActivistESEnavate Sciences GP, LLC4.8%Mar 11, 2026
ActivistVOVivo Opportunity Fund Holdings, L.P.7.4%Feb 13, 2026
ActivistFMR LLCFMR LLC9.5%Feb 5, 2026
ActivistJANUS HENDERSON GROUP PLCJANUS HENDERSON GROUP PLC12.2%Jan 8, 2026
ActivistCOCoastlands Capital LP10.0%Dec 11, 2025
Insider5L5AM Partners VI, LLCBuy $4.5MSep 11, 2025
InsiderPLPolaris Management Co. VII, L.L.C.Buy $1.9MSep 11, 2025
InsiderNANashat AmirBuy $1.9MSep 11, 2025
InsiderMJMandel-Brehm JoshBuy $10KSep 11, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
6.3M$27.9M0.0%+13.50%
0
Increased
4.9M(+0.3%)$21.8M0.0%-2.52%
28
Increased
2.6M(+8.0%)$11.6M0.0%-24.62%
30
Decreased
2M(-10.1%)$8.6M0.0%+29.04%
0
New
1.5M$6.8M0.0%+10.18%
38
Increased
456,371(+17.0%)$2M0.0%-22.55%
20
Increased
382,821(+13.8%)$1.7M0.0%-22.12%
29
New
336,047$1.5M0.0%+10.18%
35
New
195,013$860,0070.0%+10.18%
34
Increased
146,900(+270.0%)$647,8290.0%+9.33%
27
Increased
108,875(+15.2%)$480,1390.0%+36.02%
28
Increased
85,918(+750.5%)$378,8980.0%+18.74%
38
Decreased
82,450(-0.4%)$363,6050.0%-14.86%
0
Increased
78,345(+316.2%)$345,5010.0%-1.61%
26
Decreased
70,666(-5.2%)$311,6370.0%-25.04%
0
New
48,511$213,9340.0%+10.18%
32
Decreased
34,693(-52.9%)$152,9970.0%-26.45%
0
Increased
31,196(+1417x)$137,5740.0%+10.15%
24
New
24,803$109,3810.0%+10.18%
30
New
20,000$88,2000.0%+10.18%
33

Showing 1-20 of 35

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used